PURPOSE: This article summarises the evolution of microwave array applicators for heating large area chest wall disease as an adjuvant to external beam radiation, systemic chemotherapy, and potentially simultaneous brachytherapy. METHODS: Current devices used for thermotherapy of chest wall recurrence are reviewed. The largest conformal array applicator to date is evaluated in four studies: (1) ability to conform to the torso is demonstrated with a CT scan of a torso phantom and MR scan of the conformal water bolus component on a mastectomy patient; (2) specific absorption rate (SAR) and temperature distributions are calculated with electromagnetic and thermal simulation software for a mastectomy patient; (3) SAR patterns are measured with a scanning SAR probe in liquid muscle phantom for a buried coplanar waveguide CMA; and (4) heating patterns and patient tolerance of CMA applicators are characterised in a clinical pilot study with 13 patients. RESULTS: CT and MR scans demonstrate excellent conformity of CMA applicators to contoured anatomy. Simulations demonstrate effective control of heating over contoured anatomy. Measurements confirm effective coverage of large treatment areas with no gaps. In 42 hyperthermia treatments, CMA applicators provided well-tolerated effective heating of up to 500 cm(2) regions, achieving target temperatures of T(min) = 41.4 ± 0.7°C, T(90) = 42.1 ± 0.6°C, T(ave) = 42.8 ± 0.6°C, and T(max) = 44.3 ± 0.8°C as measured in an average of 90 points per treatment. CONCLUSION: The CMA applicator is an effective thermal therapy device for heating large-area superficial disease such as diffuse chest wall recurrence. It is able to cover over three times the treatment area of conventional hyperthermia devices while conforming to typical body contours.
PURPOSE: This article summarises the evolution of microwave array applicators for heating large area chest wall disease as an adjuvant to external beam radiation, systemic chemotherapy, and potentially simultaneous brachytherapy. METHODS: Current devices used for thermotherapy of chest wall recurrence are reviewed. The largest conformal array applicator to date is evaluated in four studies: (1) ability to conform to the torso is demonstrated with a CT scan of a torso phantom and MR scan of the conformal water bolus component on a mastectomy patient; (2) specific absorption rate (SAR) and temperature distributions are calculated with electromagnetic and thermal simulation software for a mastectomy patient; (3) SAR patterns are measured with a scanning SAR probe in liquid muscle phantom for a buried coplanar waveguide CMA; and (4) heating patterns and patient tolerance of CMA applicators are characterised in a clinical pilot study with 13 patients. RESULTS: CT and MR scans demonstrate excellent conformity of CMA applicators to contoured anatomy. Simulations demonstrate effective control of heating over contoured anatomy. Measurements confirm effective coverage of large treatment areas with no gaps. In 42 hyperthermia treatments, CMA applicators provided well-tolerated effective heating of up to 500 cm(2) regions, achieving target temperatures of T(min) = 41.4 ± 0.7°C, T(90) = 42.1 ± 0.6°C, T(ave) = 42.8 ± 0.6°C, and T(max) = 44.3 ± 0.8°C as measured in an average of 90 points per treatment. CONCLUSION: The CMA applicator is an effective thermal therapy device for heating large-area superficial disease such as diffuse chest wall recurrence. It is able to cover over three times the treatment area of conventional hyperthermia devices while conforming to typical body contours.
Authors: J Gellermann; W Wlodarczyk; A Feussner; H Fähling; J Nadobny; B Hildebrandt; R Felix; P Wust Journal: Int J Hyperthermia Date: 2005-09 Impact factor: 3.914
Authors: Kavitha Arunachalam; Oana I Craciunescu; Paolo F Maccarini; Jaime L Schlorff; Edward Markowitz; Paul R Stauffer Journal: Proc SPIE Int Soc Opt Eng Date: 2009-02-12
Authors: Yu Yuan; Cory Wyatt; Paolo Maccarini; Paul Stauffer; Oana Craciunescu; James Macfall; Mark Dewhirst; Shiva K Das Journal: Phys Med Biol Date: 2012-03-20 Impact factor: 3.609
Authors: H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee Journal: Int J Hyperthermia Date: 2020 Impact factor: 3.914
Authors: Yngve Birkelund; Øystein Klemetsen; Svein K Jacobsen; Kavitha Arunachalam; Paolo Maccarini; Paul R Stauffer Journal: IEEE Trans Biomed Eng Date: 2011-09-06 Impact factor: 4.538
Authors: Paul R Stauffer; Paolo F Maccarini; Kavitha Arunachalam; Valeria De Luca; Sara Salahi; Alina Boico; Oystein Klemetsen; Yngve Birkelund; Svein K Jacobsen; Fernando Bardati; Piero Tognolatti; Brent Snow Journal: Proc SPIE Int Soc Opt Eng Date: 2011-02-22
Authors: Hana Dobšíček Trefná; Johannes Crezee; Manfred Schmidt; Dietmar Marder; Ulf Lamprecht; Michael Ehmann; Jacek Nadobny; Josefin Hartmann; Nicolleta Lomax; Sultan Abdel-Rahman; Sergio Curto; Akke Bakker; Mark D Hurwitz; Chris J Diederich; Paul R Stauffer; Gerard C Van Rhoon Journal: Strahlenther Onkol Date: 2017-03-01 Impact factor: 3.621
Authors: Kavitha Arunachalam; Oana I Craciunescu; Edward J Markewitz; Paolo F Maccarini; Jaime L Schlorff; Paul R Stauffer Journal: J Appl Clin Med Phys Date: 2012-09-06 Impact factor: 2.102